ABBOTT LABORATORIES holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 92,318 | $12,245,983 | 0.21% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2025 |
| June 30, 2025 | 89,033 | $12,109,378 | 0.20% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 5, 2025 |
| Sept. 30, 2025 | 88,998 | $11,920,392 | 0.20% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 88,998 | $11,150,559 | 0.20% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 4, 2026 |
| March 31, 2026 | 88,998 | $9,137,425 | 0.18% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 4, 2026 |
| June 30, 2026 | 89,143 | $8,088,836 | 0.15% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 5, 2026 |
| Sept. 30, 2026 | 89,143 | $8,810,003 | 0.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 5, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.